Research on Pancreatic Cells Offer New Hope Diabetes Treatment

Researchers were glad to know that stem cells might be able to perform the functions of pancreatic cells in certain instances. This can be highly beneficial in lowering the risk of diabetes in one. After studying about pancreatic agenesis in detail, experts are of the opinion that the gene GATA 6 has a key role to play here.

It is a rare disorder to be born without a pancreas known as pancreatic agenesis. Pancreas has a chief role to play in one’s body from supporting the digestion process to the hormonal functions. The exocrine and the endocrine process are the two significant roles of the pancreas.

In case of one suffering from pancreatic agenesis, it has been observed that fifteen among twenty- seven people experience a mutation in this gene GATA 6. By comprehending with this relationship, the researchers seem to be assertive about treating diabetes 1 in one by producing beta cells in them.

The Peninsula College of Medicine and Dentistry has been happy to know and understand this relationship as it might support their treatment towards the treatment of diabetes.

Diabetes has been one of the most common and detrimental disorder that mankind is suffering from these days. Many diabetes medicines are there in market. Unlike diabetes 2, diabetes 1 is an auto- immune disorder that kills the beta cells of the pancreas in one impeding many crucial functions in the body. This makes it increasingly necessary for one to treat this disorder as soon as possible.

Sumagen Canada Inc. awarded $728,000 for their HIV/AIDS

National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP)

awarded Sumagen Canada Inc. a financial contribution of up to $728,000 to support their

human clinical trials for the preventative HIV/AIDS vaccine on Friday (Jan.12).

The tests are based on genetically modified ‘killed whole virus’, called SAV001.United States

Food and Drug Administration (FDA) last December gave approval to Sumagen Canada to

start the first of three phases of clinical trials.

The preliminary studies showed no adverse effects or safety risks, during test it was also

found that the HIV vaccine stimulate strong immune responses, the tests was undertaken at

University of Western Ontario. Canada is one of few countries were the development of such

kind in HIV vaccine has been undertaken.

Sumagen Canada is getting a huge assistance from NRC-IRAP under The Canadian HIV

Technology Development (CHTD) Program and Bill and Melinda Gates foundation to test the

safety of the clinical trail of first of three phases which is going to start in this month.

Canadian HIV Initiative (CHVI) initiates CHTD Program which is a partnership between

Melianda Gates foundation and Government of Canada.

28 million people have been killed due HIV/AIDS virus worldwide, and at present 35 million

people are living with the virus. Pharmaceutical companies and academic institutions all

over the world have made numerous trials since 1983 when the virus was first typified. Till

now no commercialized vaccine has been made.

Till now the vaccines that have been developed focuses on recombinant viruses carrying the

HIV genes or it concentrates on specific elements of HIV.

Tax on Sugar Beverages will Help Check Diabetes and Obesity

Nowadays not only Obesity but many other risks like diabetes, stroke, and numerous heart ailments are due to sugar based drinks. A study conducted at University California, San Francisco (UCSF) has brought statics to fore. The study proposes a penny-per-ounce tax on sweetened beverages.

A study on American residents showed that around 13.8 billion gallons of such sugar beverages is consumed every year, and a rapid increase in the number of diabetes and obesity cases. Control in heart disease occurrences and stokes will be balanced by penny-per-ounce tax on sugary drinks over the decade. It will also help prevent diabetes.

It would not only save $17 billion but help public expenses over such health problems in coming decade.

An article published in January issue of Health Affairs highlighted, being a part of chief Obesity Prevention strategies in 2009, the U.S Centers for Disease Control and Prevention had already recommended to lower the intake of sugar beverages. California and New York are currently working on this strategy of tax. That will bring down the consumption value of such beverages.

Damage Of Lungs Due To Blood Pressure Drugs To Smokers

A research from Johns Hopkins says that blood pressure drugs, which is commonly consumed by the patients, can cause lung damages to smokers, with Chronic Obstructive Pulmonary Disease which ranks third in the cause of death, in our nation.

The researchers first tried on mice, next is human. Clinical trails which includes C.O.P.D , chronic emphysema and bronchitis.

The Drug called  Losartan which is also known as Cozaar , has saved lungs from damaged, since two months of damage due to cigarette smoke. It highlights lungs tissue breakdown, airway wall thickening , inflammation and lung over expansion which cause in breathe.

          12 million Americans are suffering from C.O.P.D and there is no cure for lung damage. Only few medical attention has provided to shortness of breath, coughing, and mucus production and surgery.

           Senior investigator Dr. Enid Neptune, a Hopkins pulmonologist and an associate Professor who did research with said " Because these drugs are already approved for use in the United States as safe and effective treatments for hypertension, incorporating them into our treatment regime for C.O.P.D would be quote rapid".

           Treatment for lung damage in smokers will be the achievement, said the study of researchers in Journal of Clinical Investigation. When Hopkins research found out that same drug benefits Marfan Syndrome which cause a genetic mutation and weakness arteries, the investigation started.

Female Sexual Dysfunction Drug Fails to Reach Market

It is a shock for many that the product from BioSante Pharmaceuticals Inc has failed in its final testing. The solution is found to be less arousing than its competitive products and these reports has bought about a huge difference in the company’s market share and seems to have affected the value of its shares. However, the authorities in the firm have ordered to get the complete details for the product and plan to sort the problem as soon as possible. The representative of the company has come out that there is a partial doubt if the product has failed to satisfy the old aged consumers of is it a stress on the entire consuming population.

The product libigel phase 3 is essentially formulated for the ailments such as breast cancer and cardiovascular problems and the experts are finding the best way forward to solve the unexpected failure of the product. The representatives also came out and indicated that the company has been lucky to have maintained a stable balance sheet and it has in no way left a void in planning its experiences and trial runs. There has been a notable amount of huge sums that is spent on these activities is what is bought to the notice. Reviling the balance data of the company it is told that the firm had a cash balance of 69.6 million and it is expected that this healthy amount will clash down to around 56 million by the time the year ends.

It is not that all bad for the firm as it has a royalty deal and a cancer vaccine program with the major medicine producer Teva Pharmaceuticals (TEVA O) that will play the role of savior resource. However, the company’s losses amount to about 80 % from their previous value soon after the declaration and closed at $2.12 on NASDAQ.

Related reading: Labeling for birth control patch

New Drug (Jakafi) Approved by the FDA to Treat Myelofibrosis

No more is Myelofibrosis a threatening disorder. After so many years of research and waiting, the researchers have been able to incept a medication that can treat this rare bone disorder known as Myelofibrosis. The FDA (Food And Drug Administration) has never before approved any medication to treat this disorder. Jakafi (Ruxolitinbin) is the first successful medication that is approved by the necessary standard boards to treat the same.

Jakafi manufactured by Incyte Corporation has to be consumed twice a day. This Incyte Corporation has its partnership with Swiss Drugmaker Novartis. 

Myelofibrosis is this bone disorder where one has scares instead of the marrow that has to be present. This means the body is unable to produce the necessary blood cells. One is prone to problems like anemia and any sort of other infections in the body. One can also suffer from extrameddulary hematopoiesis. Though there is no particular cause of this severe disorder, it can result because of leukemia or lymphoma. 

Richard Pazdur who is the Director of the Office of Hematology and Oncology Products in the FDA Department has been appreciating the process of the invention of this medication where it is based on the process of understanding of disorder and the problems that the sufferer undergoes. generic viagra

This medication was out on a comparative study along with the placebo effect and other sorts of therapy like hydroxyureo. Jakafi however proved to be successful amongst all with patients experiencing 50% better results. Though like every medication, Jakafi can also have its own list of adverse effects including nausea, fatigue and thrombocytopenia. 

Avanafil details to be disclosed at the sexual medicine society meet in North American

Sildenafil and Tadalafil are couple of proficient substances which are vastly used for the reduction of erectile dysfunction (ED). This is a health ailment that is noticed in the male gender due to which they are unable to enjoy their intimate life that is the sexual life activities. Presently, there is another chemical known as Avanafil that is being developed for the similar purpose. This is taken into consideration sighting the strong developments of the male health care industry in different parts of the globe. This invention of Avanafil is ought to do a lot of good to the sexually ill people who are finding it tough to cope up with the hurdles on bed and create a successful sexual intercourse experience that satisfies their partners as well as themselves.

Avanafil is quite similar to the other sexual enhancing chemicals mentioned above; it is a strong Selective Phosphodiesterase Type 5 inhibitor for treating the erectile dysfunction discomfort from its core. The type-5 (PDE-5) medical product has been licensed from Mitsubishi Tanabe Pharmacy Corporation and is considered to be extremely safe for consumption on prescription format.

The marketing of the substance is yet to be done on a large scale and this activity is estimated to be taken in full swing as and when the company comes up with a dedicated product in the healthcare market. Nevertheless, there are certain important aspects that are to be completed and looked upon before launching the sexual improvement product with the sole inclusion of Avanafil.

However, there are strong expectations with the chemical and the products are backed to have a great run just like the top quality products which includes a very close ingredient in the form of Sildenafil Citrate (Viagra).

HPV Vaccine May Reduce Cervical Cancer Rates in Developing Countries

Human papillomavirus (HPV) is a set of over 150 viruses; know as papilloma viruses, which encourages a certain type of skin growths. Human papilloma viruses (HPV) are often connected to certain kind of cancer, also known as, carcinogenic HPVs or “high-risk," oncogenic.

Out of 150 types of HPV, 40 types of HPV are contagious, and can be transmitted from person to person during sexual interaction. The transmission of HPV can take place by genitals or oral, even if usually HPV’s is passed on sexually. It is studied that several Human papilloma virus (HPV) appear without any indications and goes away without any treatment.

The major cause of cervical cancer is high-risk HVP infection. More or less all the women have HPV infection, at some point of time, but only few develop into cervical cancer. Immune system, nearly in all the women, is suppresses or reduces HPV. Only a persistent HPV infection leads to the development of cervical cancer.

As per a study, giving human papilloma virus (HPV) vaccine dose for a longer period of time may establish an effectual way to formulate the vaccine to be obtainable to more and more women’s in the underprivileged nations.

According to the researcher, different schedules of dosing vaccine where used to conclude the treatment in the developing country.

The WorldHealth Organization (WHO) has accepted this programmatic limitation that should be considered to be initiated in the national Human papilloma virus (HPV) vaccination programs. Neuzil's team has announced that, delivering Human papilloma virus (HPV) vaccine in flexible timetable, will lets countries to  reduces the cost and increase the availability of vaccination  programs.

Lack of Vitamin D declines the level of estrogen

Vitamin D is important for a good health conditions and can be gained from food such as cereals, milk and by exposing to sunlight. Lack of vitamin D in men is amplified by lowering the levels of estrogen, but not by testosterone.

According to a previous study made deficiency of vitamin D and the low levels of estrogen are at independent threat of hardened and narrow arteries and damaged bones. A national study was carried out by the researchers, for examining the relation involving Vitamin D, bone health, and heart. It is also said that the, vitamin D supplements which can be prescribed to cure osteoporosis, can be useful to avoid heart disease.

Vitamin D, testosterone and estrogen are steroid hormones, formed from cholesterol. The level of cholesterol in blood controls bone health and arterial. Research gives a much improved understanding as to how Vitamin D, estrogen and testosterone work to affect bone health and cardiovascular health.

After using the same measure of estrogen levels, vitamin D deficiency in men were also at high risk of cardiovascular syndrome. This results support the point as to how important it is to have a appropriate quantity of vitamin D are to good for bone health and risk of rising osteoporosis and heart disease is very high on the combined interaction of how any such vitamin shortage interacts with both the sex hormones.

Natrecor a heart failure drug is found to be ineffective

A latest study published by New England Journal of Medicine says, Natrecor (nesiritide),the heart failure medicine is not effectual and is associated to increasing rates of possibly hazardous low blood pressure.

The heart failure drug Natrecor was approved in 2001 to help patients breathe without difficulty. According to the research, since the medicine had no major consequence on breathing problems or any other disease difficulty may also cause low blood pressure.

The study authors have noted that the research has recognized the possible risk and benefits of the drug in people with heart failure who have serious difficulty in breathing a condition also known as dyspnea as the illness is worsening.

To come up with new drugs, we require adequate plan and must have enough data, to rework the whole process so that the doctors and patients are comfortable. Billions of dollars were spent on Natrecor (nesiritide), where as we could have used Lasix which costs penny for single dose. We need to rethink the entire pharmaceutical industry process.

Even though, there were small non-specific effect on reducing death, re-hospitalization and improve dyspnea with nesiritide use for severely worsening heart failure. This result improves clinicians about the possible danger and benefits of Natrecor (nesiritide) in treating such patients.

In 2001 Food and Drug Administration (FDA), U.S. approved nesiritide, the anxiety were raise which may also be associated with worsening of renal functioning and mortality.

It is said that Nesiritide, shall be not be taken away from the market, as it doesn't harm anyone, just because it doesn't hurt people it doesn't means that it should be made available in the market.

Teva Loses Battle to Pfizer, Succeed Patent Challenge

Teva Pharmaceutical Industries gave a tough fight to protect the patent of the best- sold drug in the market. Teva Pharmaceutical Industries has lost the challenge, as they are not permitted to market the generic version of the Viagra.

As Pfizer Pharma has won the legal battle, and can retain the patent rights of the most blockbuster drug, that cures male impotent, called as Viagra. The major drug used for the preparation of Viagra is Slidenafil Citrate. Teva Pharmaceutical Industries will not be allowed to market the generic version of this medicine till October, 2019, by order.

As Pfizer Pharma, continues to carry on with the exclusive right into producing and marketing Viagra. The management of Pfizer Pharma is extremely content about the fact that the court has understood the necessity and the effectiveness of this drug which is used to treat erectile dysfunction (ED) or male impotent. Pfizer Pharma, also says that court has not only protected their intellectual property rights; but has also protected their patent rights from getting violated in the market.

Teva Pharmaceutical Industries builds a victorious generics industry, standing to test the patents exclusively for the owned drugs. Teva is now finding itself to the other side where they have secured its own owned products. Teva Pharmaceutical Industries has declared that even they are satisfied with the court’s result and are waiting to begin an experiment on September 7, 2011’.

Legal Action Over FDA by US Cigarette Companies

Lorillard Tobacco, Santa Fe Natural Tobacco, Commonwealth Brands, Liggett Group and, RJ
Reynolds Tobacco are the five companies that are involved in common lawsuit filed against, US
Food and Drug Administration (FDA).

All these listed major cigarette companies say that, the lawsuit has been filed against Food and Drug Administration (FDA), because the new graphic warning labels will be essential on the cigarette packets only from September 2012 onwards. The suit was filed to holdup the challenges to reinforce the upcoming new law.

In the list of complaint approximately adds 41 pages, which include saying, the newly designed
label would unlawfully force the cigarette manufactures to make their customers miserable, discouraged and terrified before purchasing their product. They are also asking Food and Drug Administration (FDA) to come-up with simple and effective uncontroversial warnings label rather then to make the cigarette pack a public notice for anti-smoking campaign by government.

All the major cigarette companies are arguing over the new law, because it is violating the constitutional right of every citizen of free speech. In the new law government wants the Cigarette companies to endorse their anti-smoking note on the pack. All the major tobacco companies have joint their hands to fight against this graphic label warning, as it is violating their freedom of speech.